Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

November 5, 2000

Study Completion Date

April 30, 2002

Conditions
Kidney Cancer
Interventions
DRUG

doxorubicin hydrochloride

DRUG

ifosfamide

Trial Locations (14)

13273

Institut J. Paoli and I. Calmettes, Marseille

30006

C.H.U. - Hopital Gaston Doumergue, Nîmes

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

35064

Centre Eugene Marquis, Rennes

44600

Centre Hospitalier General de Saint Nazaire, Saint-Nazaire

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

51056

Institut Jean Godinot, Reims

69373

Centre Leon Berard, Lyon

75181

Hotel Dieu de Paris, Paris

75248

Institut Curie - Section Medicale, Paris

84082

Institut Sainte Catherine, Avignon

92211

Centre Rene Huguenin, Saint-Cloud

06189

Centre Antoine Lacassagne, Nice

F-94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

UNICANCER

OTHER

NCT00003683 - Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter